Cancer Biotherapy and Radiopharmaceuticals This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 4, 2022 Category: Cancer & Oncology Authors: Min Liu Hui Zhang Yanli Li Shaojia Wang Source Type: research

MiR-769-5p, Which Targets HDGF, Inhibits Cell Proliferation and Invasion in Nonsmall Cell Lung Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 31, 2021 Category: Cancer & Oncology Authors: Yuejun Sun Jie Li Shiying Zheng Source Type: research

A Noncanonical Hedgehog Signaling Exerts a Tumor-Promoting Effect on Pancreatic Cancer Cells Via Induction of Osteopontin Expression
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 31, 2021 Category: Cancer & Oncology Authors: Weijiang Wu Hanqing Yang Zhutao Wang Zhijian Zhang Xiaodong Lu Wenjing Yang Xiayue Xu Yinuo Jiang Yan Li Xin Fan Qixiang Shao Source Type: research

Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 28, 2021 Category: Cancer & Oncology Authors: Simona Malaspina Pekka Taimen Markku Kallajoki Vesa Oikonen Anna Kuisma Otto Ettala Kalle Mattila Peter J. Bostr öm Heikki Minn Kari Kalliokoski Ernst J. Postema Matthew P. Miller Mika Scheinin Source Type: research

Call for Special Issue Papers: Immunotheranostics, hic sunt leones!
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 23, 2021 Category: Cancer & Oncology Authors: Martin Brechbiel Luca Filippi Source Type: research

Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-Labeled DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 15, 2021 Category: Cancer & Oncology Authors: Kamaldeep Gaurav Wanage Sarvesh Loharkar Tapas Das Sandip Basu Sharmila Banerjee Source Type: research

Impact of Radiation Dose to Circulating Immune Cells on Tumor Control and Survival in Esophageal Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 9, 2021 Category: Cancer & Oncology Authors: Shang Cai Yawen Fan Qi Guo Yanze Sun Peifeng Zhao Ye Tian Qiuhong Fan Source Type: research

Can HALP (Hemoglobin, Albumin, Lymphocytes, and Platelets) Score Differentiate Between Malignant and Benign Causes of Acute Mechanic Intestinal Obstruction?
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 8, 2021 Category: Cancer & Oncology Authors: Ahmet Akbas Serhat Koyuncu Nadir Adnan Hac ım Mehmet Fatih Dasiran Zeliha Ayd ın Kasap Ismail Okan Source Type: research

LncRNA TUG1 Promotes Hepatocellular Carcinoma Migration and Invasion Via Targeting the miR-137/AKT2 Axis
Cancer Biotherapy and Radiopharmaceuticals,Volume 36, Issue 10, Page 850-862, December 2021. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 6, 2021 Category: Cancer & Oncology Authors: Wei Li Jinzhao Ge Jinju Xie Jidong Yang Jin'e Chen Tao He Source Type: research

Myeloid Toxicity of Radionuclide Cancer Therapy
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 6, 2021 Category: Cancer & Oncology Authors: Murali Kesavan J. Harvey Turner Source Type: research

Promising Therapeutic Targets in Kidney Renal Clear Cell Carcinoma: PLXNA1 and PLXNB3
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - December 1, 2021 Category: Cancer & Oncology Authors: Can-Xuan Li Dan Long Quan Meng Source Type: research

Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - November 26, 2021 Category: Cancer & Oncology Authors: Senthamil R. Selvan Jennifer A. Brichetti Denise B. Thurber Gregory M. Botting Greg P. Bertenshaw Source Type: research

Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - November 25, 2021 Category: Cancer & Oncology Authors: Zhen Zhang Yan Mei Mingxing Hou Source Type: research

Choline Kinase Alpha Promoted Glioma Development by Activating PI3K/AKT Signaling Pathway
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - November 16, 2021 Category: Cancer & Oncology Authors: Yourui Zou Ling Huang Shengyu Sun Fangqian Yue Zhuoqi Li Yue Ma Hui Ma Source Type: research

LINC01123 Promotes the Progression of Colorectal Cancer via miR-625-5p/LASP1 Axis
Cancer Biotherapy and Radiopharmaceuticals,Volume 36, Issue 9, Page 765-773, November 2021. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - November 12, 2021 Category: Cancer & Oncology Authors: Tao Shang Xiukou Zhou Wenbin Chen Source Type: research